Related Experiment Video
Updated: Sep 15, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and Cancer Risk: results from the
Ashley H Tjaden1, Audrey A Goldbaum2, Sharon L Edelstein1
1Biostatistics Center, Milken Institute of Public Health, George Washington University, Rockville, MD, United States.
Background:
Modifying lifestyle factors may reduce the incidence of obesity, diabetes, and cancer.
Objectives:
We examined how alignment with the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Cancer Prevention Recommendations using the 2018 WCRF/AICR score was associated with incident lifestyle-related cancer in adults with prediabetes in the Diabetes Prevention Program (DPP, 1996-2001) and DPP Outcomes Study (DPPOS, 2002-2020), an observational follow-up of a randomized clinical trial.
Methods:
Participants were randomly assigned to lifestyle, metformin, or placebo interventions (mean: 3 y) and followed for an additional 19 y. The 2018 WCRF/AICR score (0-7 points; higher score, better alignment) was calculated from body weight, physical activity, diet, and alcohol components at 0, 1, 5, 6, 9, and 15 y after randomization. Incident cancer was based on the 2018 WCRF/AICR 3rd Expert Report (18 cancers associated with lifestyle). Adjusted Cox proportional hazard models estimated associations between the score (baseline [0], change from 0 to 1 y, time dependent) and lifestyle-related cancer.
Results:
Participants' (N = 3000) mean baseline WCRF/AICR score was 3.2 (SD: 1.1). There were 403 incident lifestyle-related cancer cases. Scores improved after 1 and 15 y (mean increase = 0.43 and 0.27 points, respectively, both P < 0.001). The baseline score was not associated with cancer risk. However, a 1-unit score improvement from 0 to 1 y and time-dependent scores were significantly associated with a 14% (hazard ratio [HR]: 0.86; 95% confidence interval [95% CI]: 0.76, 0.97) and 9% (HR: 0.91; 95% CI: 0.83, 0.997) lower risk, respectively, with no effect modification by intervention group or diabetes status. In exploratory by-component analyses, no single component was associated with risk.
Conclusions:
Alignment with WCRF/AICR recommendations may lower cancer risk in adults with prediabetes and type 2 diabetes, highlighting the importance of considering lifestyle factors for cancer prevention.
Trial Registration Number:
Diabetes Prevention Program, NCT00004992; Diabetes Prevention Program Outcomes Study, NCT00038727.
More Related Videos
Related Concept Videos
Cancer Prevention
Some...
Psychoneuroimmunology: Diabetes and Cancer
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Cancer Survival Analysis
Diabetes Mellitus: Type 2 and Gestational
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

